ImageneBio (IMA) Net Margin (2020 - 2025)

ImageneBio has disclosed Net Margin across 6 years of filings, most recently posting 1141.0% for Q1 2025.

• In Q1 2025, Net Margin changed N/A year-over-year to 1141.0%; the TTM figure through Sep 2025 stood at 1464.3% (down 62779.0% YoY), while the FY2023 annual figure was 744.17%, down 30370.0% from the prior year.
• Net Margin came in at 1141.0% for Q1 2025 at ImageneBio, down from 176.6% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 13.83% in Q4 2021 to a low of 5376.44% in Q2 2022.
• Average Net Margin over 5 years is 1021.36%, with a median of 372.4% recorded in 2021.
• Year-over-year, Net Margin jumped 4009537 bps in 2021 and plunged 501913 bps in 2022.
• Over 5 years, Net Margin stood at 13.83% in 2021, then slumped by 1970 bps to 258.66% in 2022, then sank by 1053 bps to 2981.94% in 2023, then surged by 94 bps to 176.6% in 2024, then slumped by 546 bps to 1141.0% in 2025.
• Per Business Quant data, the three most recent Net Margin figures were 1141.0% in Q1 2025, 176.6% in Q3 2024, and 2981.94% in Q4 2023.